In the Original Investigation titled “Identification and Validation of Plasma Metabolomic Signatures in Precancerous Gastric Lesions That Progress to Cancer,”1 published June 22, 2021, there were errors in a column of 95% CI values in Table 1. The odds ratios were correct, but each 95% CI given in the OR (95% CI) column under the IM/LGIN vs SG/CAG heading within the Validation set section was incorrect. This article has been corrected.1
Errors in Table 1. JAMA Netw Open. 2022;5(1):e2145346. doi:10.1001/jamanetworkopen.2021.45346
Customize your JAMA Network experience by selecting one or more topics from the list below.